Association of gastroduodenal disease phenotype with ABO blood group and Helicobacter pylori virulence-specific serotypes

Digestive and Liver Disease

Volumn 38, Issue 11, 2006, Pages 829-833

  Sharara, A I ^a   Abdul Baki, H ^a   ElHajj, I ^a   Kreidieh, N ^a   Kfoury Baz, E M ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Bacteria; Cag pathogenicity island; CagA; Cancer; Gastric; Peptic ulcer; VacA; Vacuolating cytotoxin

Indexed keywords

CAGA PROTEIN;

ADULT; ARTICLE; BACTERIAL VIRULENCE; BLOOD DONOR; BLOOD GROUP ABO SYSTEM; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; DUODENUM DISEASE; DUODENUM ULCER; DYSPEPSIA; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LEBANON; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; SEROPREVALENCE; SEROTYPE; STOMACH ADENOCARCINOMA; STOMACH DISEASE; STOMACH LYMPHOMA; STOMACH ULCER; SYMPTOMATOLOGY; WESTERN BLOTTING;

ABO BLOOD-GROUP SYSTEM; ADENOCARCINOMA; ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LEBANON; LYMPHOMA; MALE; MIDDLE AGED; PEPTIC ULCER; PHENOTYPE; STOMACH DISEASES;

EID: 33748934228     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.06.040     Document Type: Article

References (41)

1. Suerbaum S., and Michetti P. Helicobacter pylori infection. N Engl J Med 347 (2002) 1175-1186
2. Taylor D.N., and Blaser M.J. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 13 (1991) 42-59
3. Karlsson K.A. Animal glycosphingolipids as membrane attachment sites for bacteria. Annu Rev Biochem 58 (1989) 309-350
4. Boren T., Falk P., Roth K.A., Larson G., and Normark S. Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 262 (1993) 1892-1895
5. Davidson J.S., and Triadafilopoulos G. Blood group-related antigen expression in normal and metaplastic human upper gastrointestinal mucosa. Gastroenterology 103 (1992) 1552-1561
6. Mentis A., Blackwell C.C., Weir D.M., Spiliadis C., Dailianas A., and Skandalis N. ABO blood group, secretor status and detection of Helicobacter pylori among patients with gastric or duodenal ulcers. Epidemiol Infect 106 (1991) 221-229
7. Loffeld R.J., and Stobberingh E. Helicobacter pylori and ABO blood groups. J Clin Pathol 44 (1991) 516-517
8. Niv Y., Fraser G., Delpre G., Neeman A., Leiser A., Samra Z., et al. Helicobacter pylori infection and blood groups. Am J Gastroenterol 91 (1996) 101-104
9. Orsini B., Ciancio G., Censini S., Surrenti E., Pellegrini G., Milani S., et al. Helicobacter pylori cag pathogenicity island is associated with enhanced interleukin-8 expression in human gastric mucosa. Dig Liver Dis 32 (2000) 458-467
10. Rudi J., Rudy A., Maiwald M., Kuck D., Sieg A., and Stremmel W. Direct determination of Helicobacter pylori vacA genotypes and cagA gene in gastric biopsies and relationship to gastrointestinal diseases. Am J Gastroenterol 94 (1999) 1525-1531
11. Martin Guerrero J.M., Hergueta Delgado P., Esteban Carretero J., Romero Castro R., Pellicer Bautista F.J., and Herrerias Gutierrez J.M. Clinical relevance of Helicobacter pylori CagA-positive strains: gastroduodenal peptic lesions marker. Rev Esp Enferm Dig 92 (2000) 160-173
12. Mahachai V., Tangkijvanich P., Wannachai N., Sumpathanukul P., and Kullavanijaya P. CagA and VacA: virulence factors of Helicobacter pylori in Thai patients with gastroduodenal diseases. Helicobacter 4 (1999) 143-147
13. Maeda S., Yoshida H., Ikenoue T., Ogura K., Kanai F., Kato N., et al. Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 44 (1999) 336-341
14. Megraud F. Impact of Helicobacter pylori virulence on the outcome of gastroduodenal diseases: lessons from the microbiologist. Dig Dis 19 (2001) 99-103
15. Covacci A., Falkow S., Berg D.E., and Rappuoli R. Did the inheritance of a pathogenicity island modify the virulence of Helicobacter pylori?. Trends Microbiol 5 (1997) 205-208
16. de Jonge R., Kusters J.G., Timmer M.S., Gimmel V., Appelmelk B.J., Bereswill S., et al. The role of Helicobacter pylori virulence factors in interleukin production by monocytic cells. FEMS Microbiol Lett 196 (2001) 235-238
17. Covacci A., Telford J.L., Del Giudice G., Parsonnet J., and Rappuoli R. Helicobacter pylori virulence and genetic geography. Science 284 (1999) 1328-1333
18. Ricci V., Sommi P., and Romano M. The vacuolating toxin of Helicobacter pylori: a few answers, many questions. Dig Liver Dis 32 Suppl. 3 (2000) S178-S181
19. Nardone G. Risk factors for cancer development in Helicobacter pylori gastritis. Dig Liver Dis 32 Suppl. 3 (2000) S190-S192
20. Dundon W.G., de Bernard M., and Montecucco C. Virulence factors of Helicobacter pylori. Int J Med Microbiol 290 (2001) 647-658
21. Ito A., Fujioka T., Kodama K., Nishizono A., and Nasu M. Virulence-associated genes as markers of strain diversity in Helicobacter pylori infection. J Gastroenterol Hepatol 12 (1997) 666-669
22. Maeda S., Ogura K., Yoshida H., Kanai F., Ikenoue T., Kato N., et al. Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 42 (1998) 338-343
23. Xiang Z., Censini S., Bayeli P.F., Telford J.L., Figura N., Rappuoli R., et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 63 (1995) 94-98
24. Bach S., Makristathis A., Pinto A., Quina M., Rotter M., and Hirschl A.M. Helicobacter pylori type I strains among Austrian and Portuguese patients with gastritis, peptic ulcer or gastric cancer. Eur J Clin Microbiol Infect Dis 18 (1999) 807-810
25. Shamseddine A., Sibai A.M., Gehchan N., Rahal B., El-Saghir N., Ghosn M., et al. Cancer incidence in postwar Lebanon: findings from the first national population-based registry. Ann Epidemiol 14 (2004) 663-668
26. Gilboa S., Gabay G., Zamir D., Zeev A., and Novis B. Helicobacter pylori infection in rural settlements (Kibbutzim) in Israel. Int J Epidemiol 24 (1995) 232-237
27. Ozden A., Bozdayi G., Ozkan M., and Kose K.S. Changes in the seroepidemiological pattern of Helicobacter pylori infection over the last 10 years. Turk J Gastroenterol 15 (2004) 156-158
28. Park C.Y., Cho Y.K., Kodama T., El-Zimaity H.M., Osato M.S., Graham D.Y., et al. New serological assay for detection of putative Helicobacter pylori virulence factors. J Clin Microbiol 40 (2002) 4753-4756
29. The EUROGAST Study Group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 34 (1993) 1672-1676
30. Bravo L.E., van Doom L.J., Realpe J.L., and Correa P. Virulence-associated genotypes of Helicobacter pylori: do they explain the African enigma?. Am J Gastroenterol 97 (2002) 2839-2842
31. Louw J.A., Kidd M.S., Kummer A.F., Taylor K., Kotze U., and Hanslo D. The relationship between Helicobacter pylori infection, the virulence genotypes of the infecting strain and gastric cancer in the African setting. Helicobacter 6 (2001) 268-273
32. Graham D.Y., and Yamaoka Y. Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter 5 Suppl. 1 (2000) S3-S9 [discussion S27-31]
33. Valmaseda Perez T., Gisbert J.P., and Pajares Garcia J.M. Geographic differences and the role of cagA gene in gastroduodenal diseases associated with Helicobacter pylori infection. Rev Esp Enferm Dig 93 (2001) 471-480
34. Perez-Perez G.I., Peek R.M., Legath A.J., Heine P.R., and Graff L.B. The role of CagA status in gastric and extragastric complications of Helicobacter pylori. J Physiol Pharmacol 50 (1999) 833-845
35. Nomura A.M., Lee J., Stemmermann G.N., Nomura R.Y., Perez-Perez G.I., and Blaser M.J. Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population. J Infect Dis 186 (2002) 1138-1144
36. Parsonnet J., Friedman G.D., Orentreich N., and Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40 (1997) 297-301
37. Blaser M.J., Perez-Perez G.I., Kleanthous H., Cover T.L., Peek R.M., Chyou P.H., et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55 (1995) 2111-2115
38. Kuipers E.J., Perez-Perez G.I., Meuwissen S.G., and Blaser M.J. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst 87 (1995) 1777-1780
39. Pan Z.J., van der Hulst R.W., Feller M., Xiao S.D., Tytgat G.N., Dankert J., et al. Equally high prevalences of infection with cagA-positive Helicobacter pylori in Chinese patients with peptic ulcer disease and those with chronic gastritis-associated dyspepsia. J Clin Microbiol 35 (1997) 1344-1347
40. Shimoyama T., Fukuda S., Tanaka M., Mikami T., Saito Y., and Munakata A. High prevalence of the CagA-positive Helicobacter pylori strains in Japanese asymptomatic patients and gastric cancer patients. Scand J Gastroenterol 32 (1997) 465-468
41. Baz E.M., Mahfouz R.A., Tabarani R.S., Ayoub T.H., and Zaatari G.S. Lebanese population: prevalence of the erythrocyte phenotypes. J Med Liban 49 (2001) 140-142